GAPDH and cancer: Furthermore, we previously demonstrated that the oncogenic and mutant isoforms of p53 stabilized GAPDH cytoplasmic localization, preventing its nuclear translocation and, thus, supporting glycolysis of PDAC cells and inhibiting cancer-cell-death mechanisms mediated by nuclear GAPDH [10].